<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.ukri.org/api"><gtr:projectComposition><gtr:collaborations><gtr:collaborator url="http://gtr.ukri.org:80/organisation/7ABCBD06-3699-4CAE-96E2-E08FA09194AF"><gtr:id>7ABCBD06-3699-4CAE-96E2-E08FA09194AF</gtr:id><gtr:name>Beijing Huilongguan Hospital</gtr:name></gtr:collaborator></gtr:collaborations><gtr:leadResearchOrganisation url="http://gtr.ukri.org:80/organisation/31AF7C42-D7C4-47FF-A5D8-19AADBAD30A9"><gtr:id>31AF7C42-D7C4-47FF-A5D8-19AADBAD30A9</gtr:id><gtr:name>MRC Human Immunology Unit</gtr:name><gtr:address><gtr:line1>Weatherall Inst of Molecular Medicine</gtr:line1><gtr:line2>John Radcliffe Hospital</gtr:line2><gtr:line3>Headington</gtr:line3><gtr:line4>Oxford</gtr:line4><gtr:postCode>OX1 9DS</gtr:postCode><gtr:region>South East</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/31AF7C42-D7C4-47FF-A5D8-19AADBAD30A9"><gtr:id>31AF7C42-D7C4-47FF-A5D8-19AADBAD30A9</gtr:id><gtr:name>MRC Human Immunology Unit</gtr:name><gtr:address><gtr:line1>Weatherall Inst of Molecular Medicine</gtr:line1><gtr:line2>John Radcliffe Hospital</gtr:line2><gtr:line3>Headington</gtr:line3><gtr:line4>Oxford</gtr:line4><gtr:postCode>OX1 9DS</gtr:postCode><gtr:region>South East</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/7ABCBD06-3699-4CAE-96E2-E08FA09194AF"><gtr:id>7ABCBD06-3699-4CAE-96E2-E08FA09194AF</gtr:id><gtr:name>Beijing Huilongguan Hospital</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.ukri.org:80/person/0E155302-1387-442D-98C3-7A782273607F"><gtr:id>0E155302-1387-442D-98C3-7A782273607F</gtr:id><gtr:firstName>Xiao-Ning</gtr:firstName><gtr:surname>Xu</gtr:surname><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.ukri.org:80/projects?ref=MC_U137881015"><gtr:id>A159058A-AF5D-4B17-A6A2-6C1A4A1775B6</gtr:id><gtr:title>Immunopathogenesis of Emerging Infections Diseases in Humans</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Intramural</gtr:grantCategory><gtr:grantReference>MC_U137881015</gtr:grantReference><gtr:abstractText>Over 30 new infectious diseases have been identified including, most recently, severe acute respiratory syndrome (SARS) and the bird flu virus infection. These emerging pathogens are threatening the health of human beings. Therefore, there is an urgent need to investigate new treatments and the possibility of vaccine development. Many viruses might induce immunopathology, strong immune responses to virus infections could damage normal tissues leading to organ failure and death. Our research program is aiming to understand virus-induced pathogeneses and their immune correlates to the infections, and hopefully to provide critical information for vaccine design and new treatments.</gtr:abstractText><gtr:technicalSummary>Many viruses establish life-long infections in their natural host with few if any clinical manifestations. The relationship between virus and host is a dynamic process in which the virus has evolved the means to coexist by reducing its visibility, while the host immune system attempts to suppress and eliminate infection without damage to itself. Emerging infectious diseases pose a potential threat to public health such as human immunodeficiency virus (HIV), Severe Acute Respiratory Syndrome (SARS) virus and avian influenza. Our research focuses mainly on study of the host cellular immune responses to virus infections at the molecular, cellular and population levels. The aim is to gain a better understanding of the mechanisms of immunological damage (immunopathology) versus protection during the course of emerging pathogen infections in humans, and to apply this knowledge to the development of powerful therapies as well as effective vaccines.||Current work involves the following projects: 1) role of Nef gene in HIV-associated pathogenesis; 2) role of HGV (GBV-C) co-infection in HIV-1 pathogenesis; 3) functions of CD1 molecules and their role in virus infections; 4) immune responses to SARS coronavirus; 5) immune responses to influenza virus infection.</gtr:technicalSummary><gtr:fund><gtr:end>2010-03-31</gtr:end><gtr:funder url="http://gtr.ukri.org:80/organisation/C008C651-F5B0-4859-A334-5F574AB6B57C"><gtr:id>C008C651-F5B0-4859-A334-5F574AB6B57C</gtr:id><gtr:name>MRC</gtr:name></gtr:funder><gtr:start>2005-04-01</gtr:start><gtr:type>EXPENDITURE_ACTUAL</gtr:type><gtr:valuePounds>1402243</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs><gtr:collaborationOutput><gtr:collaboratingOrganisation>Beijing Huilongguan Hospital</gtr:collaboratingOrganisation><gtr:country>China, People's Republic of</gtr:country><gtr:description>SARS</gtr:description><gtr:id>439A25A2-FC9F-4F42-854E-ADCEC6E4CC9A</gtr:id><gtr:impact>four publications</gtr:impact><gtr:outcomeId>56dc0af91dda06.38052123-1</gtr:outcomeId><gtr:partnerContribution>SARS cohort recruitment</gtr:partnerContribution><gtr:piContribution>performing T cell responses to whole SARS genome</gtr:piContribution><gtr:sector>Hospitals</gtr:sector></gtr:collaborationOutput></gtr:collaborationOutputs><gtr:disseminationOutputs/><gtr:exploitationOutputs/><gtr:furtherFundingOutputs><gtr:furtherFundingOutput><gtr:amountPounds>55000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>BIS Focal Point-UK/China on Infectious Diseases</gtr:description><gtr:end>2011-03-02</gtr:end><gtr:fundingOrg>Department for Business, Energy &amp; Industrial Strategy</gtr:fundingOrg><gtr:id>1D019BED-6366-4374-91F3-FDB0A739E335</gtr:id><gtr:outcomeId>C596CA750140</gtr:outcomeId><gtr:sector>Public</gtr:sector><gtr:start>2007-10-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>100000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>MRC Research Grant (I)mmune correlates to an inactivated H5N1 vaccine in humans</gtr:description><gtr:end>2008-09-02</gtr:end><gtr:fundingOrg>Medical Research Council (MRC)</gtr:fundingOrg><gtr:id>D9A858F5-A286-4A82-9191-EADD76FA13E1</gtr:id><gtr:outcomeId>6D4AB6B8B290</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2007-10-01</gtr:start></gtr:furtherFundingOutput></gtr:furtherFundingOutputs><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs/><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs/><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs/><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication><gtr:id>A8595FFC-E971-4ABD-99F0-D4C847F1C07D</gtr:id><gtr:title>Generation of tumour-rejecting anti-carbohydrate monoclonal antibodies using melanoma modified with Fas ligand.</gtr:title><gtr:parentPublicationTitle>International immunology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/e067e8d445dbbd31448cdcc2eda5fa95"><gtr:id>e067e8d445dbbd31448cdcc2eda5fa95</gtr:id><gtr:otherNames>Simon AK</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0953-8178</gtr:issn><gtr:outcomeId>57692C11228</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>B16849B7-20B8-4552-9971-FD0181F9B1CF</gtr:id><gtr:title>Preexisting influenza-specific CD4+ T cells correlate with disease protection against influenza challenge in humans.</gtr:title><gtr:parentPublicationTitle>Nature medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/6728b659ca9047957546c2994120446a"><gtr:id>6728b659ca9047957546c2994120446a</gtr:id><gtr:otherNames>Wilkinson TM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1078-8956</gtr:issn><gtr:outcomeId>56d95c2960cd38.51657462</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>F628FD56-DBBB-454B-8B10-EF890612F9F8</gtr:id><gtr:title>Generation and characterisation of CD1d tetramer produced by a lentiviral expression system.</gtr:title><gtr:parentPublicationTitle>Journal of immunological methods</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/70757d4f43d859ae837579a97bdeb00f"><gtr:id>70757d4f43d859ae837579a97bdeb00f</gtr:id><gtr:otherNames>Li D</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0022-1759</gtr:issn><gtr:outcomeId>B906BBDE062</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>674728D9-E41D-4609-B616-9E516CEC623E</gtr:id><gtr:title>Depletion of CD4+CD25+ regulatory T cells enhances natural killer T cell-mediated anti-tumour immunity in a murine mammary breast cancer model.</gtr:title><gtr:parentPublicationTitle>Clinical and experimental immunology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/4864445b19a3f452037b2b692cb0926c"><gtr:id>4864445b19a3f452037b2b692cb0926c</gtr:id><gtr:otherNames>Hong H</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0009-9104</gtr:issn><gtr:outcomeId>0AFEF95CF24</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>4C69EA94-80B8-4889-ADC8-3F772302F738</gtr:id><gtr:title>T cell responses to whole SARS coronavirus in humans.</gtr:title><gtr:parentPublicationTitle>Journal of immunology (Baltimore, Md. : 1950)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/75748a5e143534eedf92ee65231cd08e"><gtr:id>75748a5e143534eedf92ee65231cd08e</gtr:id><gtr:otherNames>Li CK</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0022-1767</gtr:issn><gtr:outcomeId>27DE940F474</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>A364ADD5-D0EC-423D-B587-0BC243FD457B</gtr:id><gtr:title>HIV-1 down-regulates the expression of CD1d via Nef.</gtr:title><gtr:parentPublicationTitle>European journal of immunology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f3919cff5936bc67a9455761d5e83401"><gtr:id>f3919cff5936bc67a9455761d5e83401</gtr:id><gtr:otherNames>Chen N</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:issn>0014-2980</gtr:issn><gtr:outcomeId>9D67201743B</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>FD7F00AB-C646-48C2-87A3-4AB35468D352</gtr:id><gtr:title>A complex interplay among virus, dendritic cells, T cells, and cytokines in dengue virus infections.</gtr:title><gtr:parentPublicationTitle>Journal of immunology (Baltimore, Md. : 1950)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/d1383435e43602a50e492d78c4647d72"><gtr:id>d1383435e43602a50e492d78c4647d72</gtr:id><gtr:otherNames>Dejnirattisai W</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0022-1767</gtr:issn><gtr:outcomeId>A4E88904AF8</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>F695C5F6-6C12-4D26-9B62-E6998BD0E663</gtr:id><gtr:title>Ig-like transcript 4 inhibits lipid antigen presentation through direct CD1d interaction.</gtr:title><gtr:parentPublicationTitle>Journal of immunology (Baltimore, Md. : 1950)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/70757d4f43d859ae837579a97bdeb00f"><gtr:id>70757d4f43d859ae837579a97bdeb00f</gtr:id><gtr:otherNames>Li D</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0022-1767</gtr:issn><gtr:outcomeId>CDE86703345</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>06437D2C-AA61-4EBD-B36D-F4E310FA02CD</gtr:id><gtr:title>Human CD4+ memory T cells are preferential targets for bystander activation and apoptosis.</gtr:title><gtr:parentPublicationTitle>Journal of immunology (Baltimore, Md. : 1950)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/77853219a8282a297bce024e36ab471c"><gtr:id>77853219a8282a297bce024e36ab471c</gtr:id><gtr:otherNames>Bangs SC</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0022-1767</gtr:issn><gtr:outcomeId>C277D3B87D2</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>B5142799-033F-4FF2-AB82-5E6E32E45E17</gtr:id><gtr:title>A single amino acid defines cross-species reactivity of tree shrew (Tupaia belangeri) CD1d to human invariant natural killer T (iNKT) cells.</gtr:title><gtr:parentPublicationTitle>Immunology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/3ebd6bdb2f296d2afe5cc783a781edfc"><gtr:id>3ebd6bdb2f296d2afe5cc783a781edfc</gtr:id><gtr:otherNames>Zhang P</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0019-2805</gtr:issn><gtr:outcomeId>326067DA4CE</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>3D9B1994-1F7B-4AD7-9B67-FD635DDE26BE</gtr:id><gtr:title>A novel subset of putative stem/progenitor CD34+Oct-4+ cells is the major target for SARS coronavirus in human lung.</gtr:title><gtr:parentPublicationTitle>The Journal of experimental medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/aabb4a3c08d22654d635504cdccd286f"><gtr:id>aabb4a3c08d22654d635504cdccd286f</gtr:id><gtr:otherNames>Chen Y</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>0022-1007</gtr:issn><gtr:outcomeId>56d960e202c878.91026569</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>A7E72ECA-EAFF-4BB0-A62C-70514A563078</gtr:id><gtr:title>The open reading frame 3a protein of severe acute respiratory syndrome-associated coronavirus promotes membrane rearrangement and cell death.</gtr:title><gtr:parentPublicationTitle>Journal of virology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/39de87038ef33f889085a8a3b58da060"><gtr:id>39de87038ef33f889085a8a3b58da060</gtr:id><gtr:otherNames>Freundt EC</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0022-538X</gtr:issn><gtr:outcomeId>E3430475F01</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>43693554-A4B8-4CB6-8FF2-2EE4B3ECCD3B</gtr:id><gtr:title>NKT cells in HIV-1 infection.</gtr:title><gtr:parentPublicationTitle>Cell research</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/70757d4f43d859ae837579a97bdeb00f"><gtr:id>70757d4f43d859ae837579a97bdeb00f</gtr:id><gtr:otherNames>Li D</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>1001-0602</gtr:issn><gtr:outcomeId>1FFC69772C0</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>FDE435F0-7EA6-46E4-BC80-3E0310B4EA54</gtr:id><gtr:title>Lower cellular immune responses to influenza A (H3N2) in the elderly.</gtr:title><gtr:parentPublicationTitle>Journal of medical virology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/4d2b34f8b5a505872fbec25c0529b8e6"><gtr:id>4d2b34f8b5a505872fbec25c0529b8e6</gtr:id><gtr:otherNames>Jia N</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0146-6615</gtr:issn><gtr:outcomeId>A234D1CF474</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>3193E9CC-2728-443B-90A5-08AD257722A7</gtr:id><gtr:title>CTLs target Th cells that acquire bystander MHC class I-peptide complex from APCs.</gtr:title><gtr:parentPublicationTitle>Journal of immunology (Baltimore, Md. : 1950)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/d36c49c5369dbe76c0916f958bfdc0cb"><gtr:id>d36c49c5369dbe76c0916f958bfdc0cb</gtr:id><gtr:otherNames>Cox JH</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>0022-1767</gtr:issn><gtr:outcomeId>FDCD93BC020</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>E8124C92-3036-4B7A-A172-D58CE2828C94</gtr:id><gtr:title>Expression of elevated levels of pro-inflammatory cytokines in SARS-CoV-infected ACE2+ cells in SARS patients: relation to the acute lung injury and pathogenesis of SARS.</gtr:title><gtr:parentPublicationTitle>The Journal of pathology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c2c4fc6e139fe954c02692b5bfcb4498"><gtr:id>c2c4fc6e139fe954c02692b5bfcb4498</gtr:id><gtr:otherNames>He L</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:issn>0022-3417</gtr:issn><gtr:outcomeId>56d960e2350fc0.64365199</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>86E89F3B-6536-4F1B-A674-28BF0219CC57</gtr:id><gtr:title>Molecular determinants for subcellular localization of the severe acute respiratory syndrome coronavirus open reading frame 3b protein.</gtr:title><gtr:parentPublicationTitle>Journal of virology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/39de87038ef33f889085a8a3b58da060"><gtr:id>39de87038ef33f889085a8a3b58da060</gtr:id><gtr:otherNames>Freundt EC</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0022-538X</gtr:issn><gtr:outcomeId>7730C7B7671</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>D5ADFEE9-AB23-4AEE-AE2F-FC73DB57AA7C</gtr:id><gtr:title>Comparing pooled peptides with intact protein for accessing cross-presentation pathways for protective CD8+ and CD4+ T cells.</gtr:title><gtr:parentPublicationTitle>The Journal of biological chemistry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/1bde23452702f3d087e5f35cb87dd0e1"><gtr:id>1bde23452702f3d087e5f35cb87dd0e1</gtr:id><gtr:otherNames>Zhang H</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0021-9258</gtr:issn><gtr:outcomeId>40D5FD15F07</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>6A84C647-AF4B-4858-8644-C00EE1F9A577</gtr:id><gtr:title>Bystander T cell activation--implications for HIV infection and other diseases.</gtr:title><gtr:parentPublicationTitle>Trends in immunology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/77853219a8282a297bce024e36ab471c"><gtr:id>77853219a8282a297bce024e36ab471c</gtr:id><gtr:otherNames>Bangs SC</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:issn>1471-4906</gtr:issn><gtr:outcomeId>09A21BDA18E</gtr:outcomeId></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">MC_U137881015</gtr:identifier></gtr:identifiers><gtr:healthCategories><gtr:healthCategory><gtr:id>03BA7BC9-C251-48FC-8EA9-5F7414A63FEE</gtr:id><gtr:percentage>50</gtr:percentage><gtr:text>Infection</gtr:text></gtr:healthCategory><gtr:healthCategory><gtr:id>C6D70A71-8796-47BC-AFE0-CC2286E66A06</gtr:id><gtr:percentage>50</gtr:percentage><gtr:text>Inflammatory and Immune System</gtr:text></gtr:healthCategory></gtr:healthCategories><gtr:researchActivities><gtr:researchActivity><gtr:id>1BF330A9-C7B5-49C5-B54B-CF4FAE6DF1D8</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>2.1  Biological and endogenous factors</gtr:text></gtr:researchActivity></gtr:researchActivities><gtr:researchSubjects/><gtr:researchTopics/><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>